Bookrunners Ladenburg Thalmann and Craig-Hallum Capital Group assist
By Devika Patel
Knoxville, Tenn., June 17 – Viveve Medical, Inc. said the underwriters for its public offering of stock opted to exercise the deal’s $2.03 million greenshoe in full, lifting total proceeds of the offering to $15.53 million.
The deal was announced on May 24 and priced for $13.5 million with the greenshoe on June 14.
The company sold 3,105,000 common shares at $5.00 per share. The price per share is identical to the June 13 closing share price. Of the shares, 405,000 were part of the fully exercised greenshoe.
Ladenburg Thalmann & Co. Inc. and Craig-Hallum Capital Group were the bookrunners.
Proceeds will be used for general corporate purposes.
Based in Sunnyvale, Calif., Viveve is a medical device company.
| Issuer: | Viveve Medical, Inc.
|
| Issue: | Common stock
|
| Amount: | $15,525,000, including $2,025,000 greenshoe of 405,000 shares
|
| Shares: | 3,105,000
|
| Price: | $5.00
|
| Warrants: | No
|
| Bookrunners: | Ladenburg Thalmann & Co. Inc. and Craig-Hallum Capital Group
|
| Co-manager: | Maxim Group LLC
|
| Announcement date: | May 24
|
| Pricing date: | June 14
|
| Settlement date: | June 17
|
| Stock symbol: | Nasdaq: VIVE
|
| Stock price: | $5.00 at close June 13
|
| Market capitalization: | $37.41 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
